Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11779631 CD47 blockade therapy by HDAC inhibitors
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
Date Filed
November 1, 2017
Date of Patent
October 10, 2023
Patent Applicant
Trillium Therapeutics
Patent Application Number
16344985
Patent Citations
US Patent 9650441 Anti-CD47 antibodies and methods of use
US Patent 8377448 CD47 related compositions and methods for treating immunological diseases and disorders
US Patent 8562997 Methods of treating acute myeloid leukemia by blocking CD47
US Patent 9803016 Anti-CD47 antibodies and methods of use
Patent Inventor Names
Emma Linderoth
Natasja Nielsen Viller
Penka Slavcheva Slavova-Petrova
Robert Adam Uger
Patent Jurisdiction
United States Patent and Trademark Office
Patent Number
11779631
Patent Primary Examiner
Alana Harris Dent
CPC Code
A61P 35/00
A61P 35/02
C07K 14/70596
C07K 16/2803
C07K 2317/76
A61K 39/39541
A61K 39/395
A61K 38/1709
A61K 38/15
A61K 31/395
•••
Find more entities like US Patent 11779631 CD47 blockade therapy by HDAC inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE